Jason McCarthy

Jul 20, 2026

Jason McCarthy rated AKTX as Buy on Jul 20, 2026, setting a price target of 30. The stock has underperformed, dropping 12.80% despite the bullish target of 30.

Jul 20, 2026

On Jul 20, 2026, RNTX was given a Buy rating by Jason McCarthy, with a target price of 4. The stock rallied 6.02% after the rating, narrowing the gap to the target of 4 and validating the bullish stance.

Jun 16, 2026

CNTX received a Buy rating from Jason McCarthy on Jun 16, 2026, aiming for 4. Price action was muted, as shares hovered around 0.63 despite the bullish outlook.

Jun 10, 2026

On Jun 10, 2026, Jason McCarthy published a Buy outlook on ZVRA, with a target of 35. Market action contradicted the Buy thesis, as shares slipped to 12.45.

Jun 03, 2026

Jason McCarthy on Jun 03, 2026 assigned RZLT a Buy rating, with a price target of 14. The Buy call aligned well with market performance, producing a gain of 11.14%.

May 26, 2026

On May 26, 2026, Jason McCarthy reaffirmed FLNA with a Buy rating, targeting 5. Shares slid 28.37% despite the recommendation, highlighting downside risks.

May 18, 2026

NTHI was rated Buy by Jason McCarthy on May 18, 2026, with a price objective of 20. This case shows how bullish projections can fail, with the stock now below 3.37.

May 15, 2026

On May 15, 2026, Jason McCarthy initiated coverage on CMPS with a Buy rating and target of 20. The stock’s climb of 17.45% since the call highlights the foresight in the rating.

Apr 17, 2026

Jason McCarthy issued a Buy recommendation for IMNN on Apr 17, 2026, price target set at 10. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

Mar 31, 2026

On Mar 31, 2026, TOVX was evaluated by Jason McCarthy, who gave a Buy rating and target of 1. This case illustrates how a timely bullish rating can translate into tangible gains of 17.47%.

Mar 23, 2026

Jason McCarthy rated MNOV as Buy on Mar 23, 2026, setting a price target of 6. The stock has underperformed, dropping 8.28% despite the bullish target of 6.

Mar 12, 2026

On Mar 12, 2026, SLS was given a Buy rating by Jason McCarthy, with a target price of 10. The stock rallied 156.46% after the rating, narrowing the gap to the target of 10 and validating the bullish stance.

Mar 10, 2026

CLRB received a Buy rating from Jason McCarthy on Mar 10, 2026, aiming for 10. The rating hasn’t played out as hoped, with the stock trading 15.41% below expectations.

Feb 27, 2026

On Feb 27, 2026, Jason McCarthy published a Buy outlook on PLYX, with a target of 10. Market action contradicted the Buy thesis, as shares slipped to 2.32.

Dec 04, 2025

CAPR was rated Buy by Jason McCarthy on Dec 04, 2025, with a price objective of 50. This case shows how bullish projections can fail, with the stock now below 19.79.

Oct 07, 2025

Jason McCarthy rated GANX as Buy on Oct 07, 2025, setting a price target of 7. The stock has underperformed, dropping 8.91% despite the bullish target of 7.

Oct 02, 2025

On Oct 02, 2025, HIND was given a Buy rating by Jason McCarthy, with a target price of 15. Despite the Buy call, shares fell from 2.18 to 2.18, challenging the optimistic stance.

Sep 30, 2025

ADIL received a Buy rating from Jason McCarthy on Sep 30, 2025, aiming for 1.5. The rating hasn’t played out as hoped, with the stock trading 69.00% below expectations.

Sep 24, 2025

On Sep 24, 2025, Jason McCarthy published a Buy outlook on AZTR, with a target of 4. Market action contradicted the Buy thesis, as shares slipped to 0.1357.

Sep 12, 2025

Jason McCarthy on Sep 12, 2025 assigned CNSP a Buy rating, with a price target of 20. The call has struggled to gain traction, with shares losing 27.06%.

Sep 11, 2025

On Sep 11, 2025, Jason McCarthy reaffirmed NEUP with a Buy rating, targeting 35. Shares slid 76.13% despite the recommendation, highlighting downside risks.

Sep 04, 2025

CHRS was rated Buy by Jason McCarthy on Sep 04, 2025, with a price objective of 4. A bullish response from the market helped close the gap of 2.53 to the target.

Aug 18, 2025

On Aug 18, 2025, Jason McCarthy initiated coverage on PSTV with a Buy rating and target of 3. The Buy call has yet to be validated as shares remain -0.92 away from the target.

Aug 15, 2025

Jason McCarthy issued a Buy recommendation for RVPH on Aug 15, 2025, price target set at 2. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

Jul 02, 2025

Jason McCarthy rated INMB as Buy on Jul 02, 2025, setting a price target of 8. The stock has underperformed, dropping 16.53% despite the bullish target of 8.

Jun 11, 2025

On Jun 11, 2025, KZIA was given a Buy rating by Jason McCarthy, with a target price of 15. The stock rallied 48.32% after the rating, narrowing the gap to the target of 15 and validating the bullish stance.

Mar 27, 2025

KAPA received a Buy rating from Jason McCarthy on Mar 27, 2025, aiming for 4. The rating hasn’t played out as hoped, with the stock trading 63.09% below expectations.

Mar 25, 2025

On Mar 25, 2025, Jason McCarthy published a Buy outlook on MBRX, with a target of 4. Market action contradicted the Buy thesis, as shares slipped to 2.15.

Mar 21, 2025

Jason McCarthy on Mar 21, 2025 assigned ANIX a Buy rating, with a price target of 10. The Buy call aligned well with market performance, producing a gain of 12.66%.

Mar 10, 2025

On Mar 10, 2025, Jason McCarthy reaffirmed ONCY with a Buy rating, targeting 3. The recommendation was supported by strong follow-through as the stock rose from 0.8585 to 0.8585.

Jan 30, 2025

ATHE was rated Buy by Jason McCarthy on Jan 30, 2025, with a price objective of 12. A bullish response from the market helped close the gap of 7.02 to the target.

Jan 23, 2025

On Jan 23, 2025, Jason McCarthy initiated coverage on NAYA with a Buy rating and target of 2. The Buy call has yet to be validated as shares remain -0.20 away from the target.

Dec 17, 2024

Jason McCarthy issued a Buy recommendation for MDCX on Dec 17, 2024, price target set at 10. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

Nov 15, 2024

On Nov 15, 2024, BLTE was evaluated by Jason McCarthy, who gave a Buy rating and target of 110. This case illustrates how a timely bullish rating can translate into tangible gains of 94.52%.

Oct 22, 2024

Jason McCarthy rated AIM as Buy on Oct 22, 2024, setting a price target of 1. The stock has underperformed, dropping 7.43% despite the bullish target of 1.

Sep 24, 2024

On Sep 24, 2024, MESO was given a Buy rating by Jason McCarthy, with a target price of 12. The stock rallied 125.86% after the rating, narrowing the gap to the target of 12 and validating the bullish stance.

Jul 11, 2024

On Jul 11, 2024, Jason McCarthy published a Buy outlook on SNPX, with a target of 14. Shares gained 80.05%, underscoring the accuracy of the bullish outlook toward 14.

Jun 20, 2024

Jason McCarthy on Jun 20, 2024 assigned VIRI a Buy rating, with a price target of 1. The call has struggled to gain traction, with shares losing 97.62%.

May 08, 2024

On May 08, 2024, Jason McCarthy reaffirmed NRBO with a Buy rating, targeting 10. Shares slid 39.95% despite the recommendation, highlighting downside risks.